By Amina Niasse NEW YORK, Nov 14 (Reuters) – CVS Health said employers and other health plan sponsors could break even on GLP-1 drugs if they are priced below $350 per month as reduced use of medical
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(adds quotes, background) MANILA, Nov 14 (Reuters) - ASEAN is not relaxing its approach to…
Here are the top stories and upcoming coverage plans for Reuters text service as of…
JAKARTA, Nov 14 (Reuters) - Indonesian President Prabowo Subianto said on Saturday that the state…
LONDON, Nov 14 (Reuters) - Britain's King Charles joked that he and Elton John were…
ZELENSKIY SAYS US NEGOTIATORS RAISED A QUESTION IF UKRAINE WAS READY TO CEDE DONBAS IF…
LONDON, Nov 14 (Reuters) - Britain's King Charles joked that he and Elton John were…